Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Calypte Biomedical has announced that its Chinese subsidiary, Beijing Marr Bio-Pharmaceutical, has received registration and marketing approval for Calypte's Aware HIV-1/2 OMT rapid test from the State Food and Drug Administration of China.
Subscribe to our email newsletter
This approval makes the Aware HIV-1/2 OMT test the first and only State Food and Drug Administration approved rapid oral fluid HIV test in China.
David Harris, Beijing Marr’s CEO, said: “We now plan to ramp up our production capacity as we build our distribution network to fully realize the market potential of the Aware HIV-1/2 OMT test in China.”